BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Zampino R, Marrone A, Restivo L, Guerrera B, Sellitto A, Rinaldi L, Romano C, Adinolfi LE. Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. World J Hepatol 2013; 5(10): 528-540 [PMID: 24179612 DOI: 10.4254/wjh.v5.i10.528]
URL: https://www.wjgnet.com/1948-5182/full/v5/i10/528.htm
(384) (305) (0) (0) (12756) (180)
Number Citing Articles
1
Syed Yasir Abbas, Hafsa Auroj, Arshad Sattar Lakho, Akbar Gohar Abro, Ghulam Shahar Bano, Tahir Hanif Rajput. Frequency Of Peripheral Neuropathy in Chronic Hepatitis C Patients Presenting at Liaquat University Hospital, Hyderabad. Pakistan BioMedical Journal 2022;  doi: 10.54393/pbmj.v5i5.473
2
O.O. Olubamwo, A.O. Aregbesola, J. Miettola, J. Kauhanen, T.-P. Tuomainen. Hepatitis C and risk of coronary atherosclerosis – A systematic review. Public Health 2016; 138 doi: 10.1016/j.puhe.2016.04.005
3
Jelena S Jadzic, Andreja B Baljozovic, Ljubica D Simic. Bone health and chronic viral infections: A narrative literature review. World Journal of Virology 2026; 15(1): 118225 doi: 10.5501/wjv.v15.i1.118225
4
Shari S. Rogal, Klaus Bielefeldt, Ajay D. Wasan, Eva Szigethy, Francis Lotrich, Andrea F. DiMartini. Fibromyalgia Symptoms and Cirrhosis. Digestive Diseases and Sciences 2015; 60(5) doi: 10.1007/s10620-014-3453-3
5
Ida Fortini, Eustáquio Martins Gomes Arouca, Fatima Mitiko Tengam, Ricardo Nitrini. Chronic HCV infection and neuropsychiatric dysfunction. eNeurologicalSci 2019; 17 doi: 10.1016/j.ensci.2019.100206
6
Takashi Kumada, Hidenori Toyoda, Satoshi Yasuda, Toshifumi Tada, Takanori Ito, Junko Tanaka. Long‐term outcomes of viral eradication in patients with hepatitis C virus infection and mild hepatic fibrosis. Journal of Viral Hepatitis 2021; 28(9) doi: 10.1111/jvh.13562
7
Tangui Barré, Marie Libérée Nishimwe, Camelia Protopopescu, Fabienne Marcellin, Fabrice Carrat, Céline Dorival, Elisabeth Delarocque‐Astagneau, Dominique Larrey, Marc Bourlière, Ventzislava Petrov‐Sanchez, Mélanie Simony, Stanislas Pol, Hélène Fontaine, Patrizia Carrieri. Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C‐infected patients (ANRS CO22 Hepather cohort). Journal of Viral Hepatitis 2020; 27(12) doi: 10.1111/jvh.13380
8
O. V. Masalova, E. I. Lesnova, E. I. Samokhvalov, K. Yu. Permyakova, A. V. Ivanov, S. N. Kochetkov, A. A. Kushch. Low-molecular-weight regulators of biogenic polyamine metabolism affect cytokine production and expression of hepatitis С virus proteins in Huh7.5 human hepatocarcinoma cells. Molecular Biology 2017; 51(3) doi: 10.1134/S0026893317030128
9
Syeda Zainab Ilyas, Rabia Tabassum, Haroon Hamed, Shafiq Ur Rehman, Ishtiaq Qadri. Hepatitis C Virus-Associated Extrahepatic Manifestations in Lung and Heart and Antiviral Therapy-Related Cardiopulmonary Toxicity. Viral Immunology 2017; 30(9) doi: 10.1089/vim.2017.0009
10
Pasquale Ambrosino, Luciano Tarantino, Giovanni Di Minno, Mariano Paternoster, Vincenzo Graziano, Maurizio Petitto, Aurelio Nasto, Matteo Nicola Di Minno. The risk of venous thromboembolism in patients with cirrhosis. Thrombosis and Haemostasis 2017; 117(01) doi: 10.1160/TH16-06-0450
11
Chunlin Jiang, Jianting Long, Baoxian Liu, Xiaoyan Xie, Ming Kuang. Mcl-1 Is a Novel Target of miR-26b That Is Associated with the Apoptosis Induced by TRAIL in HCC Cells. BioMed Research International 2015; 2015 doi: 10.1155/2015/572738
12
Hanqing Chen. Iron metabolism in non-alcoholic fatty liver disease: A promising therapeutic target. Liver Research 2022; 6(4) doi: 10.1016/j.livres.2022.09.003
13
Annalisa Cespiati, Marica Meroni, Rosa Lombardi, Giovanna Oberti, Paola Dongiovanni, Anna Ludovica Fracanzani. Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies. Biomedicines 2022; 10(1) doi: 10.3390/biomedicines10010182
14
Matías E. Gómez, Emiliano A. Gentile, M. Florencia Martini, María L. Cuestas, Verónica L. Mathet, Graciela Y. Moltrasio, Albertina G. Moglioni. Synthesis of New Indanyl Nucleoside Analogues and their Biological Evaluation on Hepatitis C Virus (HCV) Replicon. Molecules 2019; 24(5) doi: 10.3390/molecules24050990
15
Ahmed A. Elamragy, Juliette Bahgat Mesak, Wael Mohamed Elnaggar, Karim Said, Marwa Sayed Meshaal. Speckle Tracking Echocardiography: The Secret Key To Predicting Poor Outcomes in Infective Endocarditis. Cor et Vasa 2026; 68(1) doi: 10.33678/cor.2025.104
16
Katharina Büsch, Jesper Waldenström, Martin Lagging, Soo Aleman, Ola Weiland, Jan Kövamees, Ann-Sofi Duberg, Jonas Söderholm. Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden. Scandinavian Journal of Gastroenterology 2017; 52(1) doi: 10.1080/00365521.2016.1228119
17
Luigi Elio Adinolfi, Riccardo Nevola, Luca Rinaldi, Ciro Romano, Mauro Giordano. Chronic Hepatitis C Virus Infection and Depression. Clinics in Liver Disease 2017; 21(3) doi: 10.1016/j.cld.2017.03.007
18
Zobair M Younossi, Maria Stepanova, Tarik Asselah, Graham Foster, Keyur Patel, Norbert Bräu, Mark Swain, Tram Tran, Rafael Esteban, Massimo Colombo, Stephen Pianko, Linda Henry, Marc Bourliere. Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes. Clinical Infectious Diseases 2018; 66(11) doi: 10.1093/cid/cix1106
19
Chester J. Donnally, Parthik D. Patel, Jose A. Canseco, Kartik Shenoy, Srikanth N. Divi, Vadim Goz, Abdul R. Arain, Alexander R. Vaccaro. Hepatitis C Virus Infection as a Predictor of Complications and Increased Costs Following Primary Lumbar Fusion Surgery. Spine 2020; 45(16) doi: 10.1097/BRS.0000000000003481
20
Theodoros Androutsakos, Dimitrios Mouziouras, Stamatia Katelani, Mina Psichogiou, Petros P. Sfikakis, Athanase D. Protogerou, Antonios A. Argyris. A Comparative Study on the Presence and Reversibility of Subclinical Arterial Damage in HCV-Infected Individuals and Matched Controls. Viruses 2023; 15(6) doi: 10.3390/v15061374
21
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes. Cancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1821
22
Benny Mosoane, Shobana Sampath, Zodwa Dlamini. The Exposome in Cancer Disparities. 2026;  doi: 10.1016/B978-0-443-44322-0.00016-1
23
Stephanie Chan, Jing-hsiung Ou. Hepatitis C Virus-Induced Autophagy and Host Innate Immune Response. Viruses 2017; 9(8) doi: 10.3390/v9080224
24
Hyun Min Kim, Yong-ho Lee, Kyungdo Han, Byung-Wan Lee, Eun Seok Kang, Jaetaek Kim, Bong-Soo Cha. Impact of diabetes mellitus and chronic liver disease on the incidence of dementia and all-cause mortality among patients with dementia. Medicine 2017; 96(47) doi: 10.1097/MD.0000000000008753
25
Anna Chudnovets, Jin Liu, Harish Narasimhan, Yang Liu, Irina Burd, Sabra Klein. Role of Inflammation in Virus Pathogenesis during Pregnancy. Journal of Virology 2020; 95(2) doi: 10.1128/JVI.01381-19
26
Hrvoje Roguljic, Vjera Nincevic, Kristina Bojanic, Lucija Kuna, Robert Smolic, Aleksandar Vcev, Dragan Primorac, Andrijana Vceva, George Y. Wu, Martina Smolic. Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.678546
27
Moses New-Aaron, Lukman A. Adepoju, Anup Singh Pathania, Kusum K. Kharbanda, Natalia A. Osna. Hepatocyte-Derived Apoptotic Bodies as Pathological Intercellular Messengers in the Liver. Biomolecules 2026; 16(2) doi: 10.3390/biom16020198
28
Ragunath Singaravelu, Rodney S Russell, D Lorne Tyrrell, John Paul Pezacki. Hepatitis C virus and microRNAs: miRed in a host of possibilities. Current Opinion in Virology 2014; 7 doi: 10.1016/j.coviro.2014.03.004
29
Alessandra Rodrigues de Camargo, Jefferson Rocha Tenório, Fabiana Martins, Liliane Janete Grando, Esther Buzaglo Dantas Corrêa, Marília Trierveiler, Karem L. Ortega. Subset of CD8+ and FOXP3 + T cells in lichen planus associated with chronic hepatitis C infection. Oral Diseases 2019; 25(4) doi: 10.1111/odi.13069
30
Michael Broker, Shalom Z. Frager, Nayan S. Patel, Edward Lebovics, William H. Frishman. The Inflammatory Relationship Between Hepatitis C Virus With Coronary and Carotid Atherosclerosis. Cardiology in Review 2021; 29(4) doi: 10.1097/CRD.0000000000000314
31
Hemalatha Mani, Jui-Hung Yen, Hao-Jen Hsu, Chun-Chun Chang, Je-Wen Liou. Hepatitis C virus core protein. Tzu Chi Medical Journal 2022; 34(2) doi: 10.4103/tcmj.tcmj_97_21
32
Jonas Söderholm, Charlotta Millbourn, Katharina Büsch, Jan Kövamees, Robert Schvarcz, Karin Lindahl, Annette Bruchfeld. Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis. Journal of Hepatology 2018; 68(5) doi: 10.1016/j.jhep.2017.12.003
33
Thomas A. Verbeek, Jonathan G. Stine, Fuat H. Saner, Dmitri Bezinover. Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management. Transplantation Direct 2018; 4(11) doi: 10.1097/TXD.0000000000000843
34
Yingying Lin, Xinyu Cui, Na Zhu, Yanyan Li, Peng Wang, Xin Wang, Yunyun Yi, Xin Li. Association Between Retinol-Binding Protein 4 Levels and Hepatitis C Virus Infection: A Meta-Analysis. Diseases 2024; 12(11) doi: 10.3390/diseases12110291
35
Chuang Yang, Zhibo Li, Zhuo Zhao, Ziyuan Guo. Oncoviruses as Emerging Players in Cardiovascular Pathogenesis: Evidence, Mechanisms and Clinical Perspectives. Reviews in Medical Virology 2026; 36(1) doi: 10.1002/rmv.70097
36
Pedro Molina-Sánchez, Amaia Lujambio. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019;  doi: 10.1007/978-3-030-21540-8_16
37
E Rosenthal, P Cacoub. Extrahepatic manifestations in chronic hepatitis C virus carriers. Lupus 2015; 24(4-5) doi: 10.1177/0961203314556140
38
Sichao WANG, Weixia SUN, Yiping CHENG, Lei WANG, Shizhan MA, Fei JING, Xiujuan ZHANG, Xinli ZHOU. Relationship between plasma 12,13-diHOME level and nonalcoholic fatty liver disease in patients with type 2 diabetes and obesity. Minerva Endocrinology 2025; 50(1) doi: 10.23736/S2724-6507.21.03424-6
39
Alexia Anastasia Stefania Balta, Mariana Daniela Ignat, Raisa Eloise Barbu, Caterina Dumitru, Diana Sabina Radaschin, Valentin Bulza, Silvia Aura Mateescu Costin, Catalin Pleșea-Condratovici, Liliana Baroiu. Impact of Direct-Acting Antivirals on Extrahepatic Manifestations in Chronic Hepatitis C: A Narrative Review with a Hermeneutic Approach. Healthcare 2025; 13(16) doi: 10.3390/healthcare13161953
40
Nancy Reau, Francis Vekeman, Eric Wu, Yanjun Bao, Yuri Sanchez Gonzalez. Prevalence and economic burden of extrahepatic manifestations of hepatitis C virus are underestimated but can be improved with therapy. Hepatology Communications 2017; 1(5) doi: 10.1002/hep4.1049
41
Luigi Elio Adinolfi, Luca Rinaldi, Riccardo Nevola. Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?. World Journal of Gastroenterology 2018; 24(41): 4617-4621 doi: 10.3748/wjg.v24.i41.4617
42
Zakaria Boulahtouf, Alessia Virzì, Thomas F. Baumert, Eloi R. Verrier, Joachim Lupberger. Signaling Induced by Chronic Viral Hepatitis: Dependence and Consequences. International Journal of Molecular Sciences 2022; 23(5) doi: 10.3390/ijms23052787
43
Alicja E. Grzegorzewska, Adrianna Mostowska, Wojciech Warchoł, Paweł P. Jagodziński. Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case–control study. BMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-06597-4
44
Andreea Florentina Stoenescu, Corneliu Petru Popescu, Simin Aysel Florescu, Geta Vancea, Emanoil Ceausu, Petre Calistru. The Prevalence of Depression and Its Potential Link to Liver Fibrosis in Patients Diagnosed With Chronic Hepatitis C Virus Infection Prior to the Initiation of Direct-Acting Antiviral Treatment. Cureus 2024;  doi: 10.7759/cureus.62970
45
Alessia Virzì, Armando Andres Roca Suarez, Thomas F. Baumert, Joachim Lupberger. Oncogenic Signaling Induced by HCV Infection. Viruses 2018; 10(10) doi: 10.3390/v10100538
46
Hans-Peter Kapfhammer. Depression, Angst, traumatischer Stress und internistische Erkrankungen. 2022;  doi: 10.1007/978-3-662-65873-4_7
47
Michele Nardone, Dario Di Stasio, Alberta Lucchese, Daniele Gentili, Giulia Cattabianchi, Carlo Signorelli, Pierangelo Sarchi, Giovanna Pulcrano, Valentino Lembo, Paola Maria Pirola, Dorina Lauritano, Francesco Carinci. Hepatitis C Epidemiology: Insights from a Comprehensive Cohort Study in ASST Melegnano and Martesana, Lombardia Region, Northern Italy. Pathogens 2024; 13(3) doi: 10.3390/pathogens13030215
48
Chih‐Wen Wang, Szu‐Chia Chen, Chung‐Feng Huang, Ho‐Ming Su, Jiun‐Chi Huang, Pei‐Yu Wu, Ming‐Lun Yeh, Pei‐Lun Lee, Chia‐Yen Dai, Jee‐Fu Huang, Ming‐Lung Yu, Wan‐Long Chuang. Hepatitis C virus infection increases risk of peripheral arterial disease in end‐stage renal disease patients receiving maintenance hemodialysis therapy. Advances in Digestive Medicine 2025; 12(3) doi: 10.1002/aid2.13432
49
Dean L. Winslow. Hepatitis C virus infection and cardiac dysfunction in women. AIDS 2021; 35(10) doi: 10.1097/QAD.0000000000002938
50
M. Jadoul, A.A. Awan, M.C. Berenguer, A. Bruchfeld, F. Fabrizi, D.S. Goldberg, J. Jia, N. Kamar, R. Mohamed, M.G. Pessôa, S. Pol, M.E. Sise, P. Martin. KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney International 2022; 102(6) doi: 10.1016/j.kint.2022.07.013
51
Marina Serper. Direct acting antivirals for patients without advanced liver disease: All for treatment and treatment for all?. Hepatology 2018; 68(3) doi: 10.1002/hep.29873
52
Donald D Anthony, Mark S Sulkowski, Laura M Smeaton, Sofi Damjanovska, Carey L Shive, Corinne M Kowal, Daniel E Cohen, Debika Bhattacharya, Beverly L Alston-Smith, Ashwin Balagopal, David L Wyles. Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus–HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation. The Journal of Infectious Diseases 2020; 222(8) doi: 10.1093/infdis/jiaa254
53
Ming-Shyan Lin, Chang-Min Chung, Ming-Ling Chang, Mei-Yen Chen, Shih-Tai Chang, Pao-Hsien Chu, Tien-Hsing Chen, Wey-Yil Lin, Tung-Jung Huang, Yu-Sheng Lin. The Unraveled Link Between Antiviral Therapy and Heart Failure Hospitalization in Chronic Hepatitis C Virus Infection　― A Nationwide Cohort Study ―. Circulation Journal 2018; 82(6) doi: 10.1253/circj.CJ-17-1118
54
Daniel J. Ruzicka, Jumpei Tetsuka, Go Fujimoto, Tatsuya Kanto. Comorbidities and co-medications in populations with and without chronic hepatitis C virus infection in Japan between 2015 and 2016. BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3148-z
55
Ping‐Jen Hu, Pei‐Chien Tsai, Chi‐Yi Chen, Hsing‐Tao Kuo, Chao‐Hung Hung, Kuo‐Chih Tseng, Hsueh‐Chou Lai, Cheng‐Yuan Peng, Jing‐Houng Wang, Jyh‐Jou Chen, Pei‐Lun Lee, Rong‐Nan Chien, Chi‐Chieh Yang, Gin‐Ho Lo, Jia‐Horng Kao, Chun‐Jen Liu, Chen‐Hua Liu, Sheng‐Lei Yan, Chun‐Yen Lin, Wei‐Wen Su, Cheng‐Hsin Chu, Chih‐Jen Chen, Shui‐Yi Tung, Chi‐Ming Tai, Chih‐Wen Lin, Ching‐Chu Lo, Pin‐Nan Cheng, Yen‐Cheng Chiu, Chia‐Chi Wang, Jin‐Shiung Cheng, Wei‐Lun Tsai, Han‐Chieh Lin, Yi‐Hsiang Huang, Ming‐Lun Yeh, Chung‐Feng Huang, Meng‐Hsuan Hsieh, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chung, Yen‐Hsiange Wang, Ming‐Lung Yu, Ming‐Jong Bair. Impact of Hepatitis C Virus Clearance on Cardiovascular Risk: A Real‐World Experience From the Nationwide Taiwan Hepatitis C Virus Registry. The Kaohsiung Journal of Medical Sciences 2025; 41(8) doi: 10.1002/kjm2.70036
56
Vukica Đorđević, Dobrila Stanković Đorđević, Branislava Kocić, Marina Dinić, Danka Sokolović, Jana Pešić Stanković, Daniele Vergara. The Impact of Hepatitis C Virus Genotypes on Oxidative Stress Markers and Catalase Activity. Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/6676057
57
Lucio Boglione, Tommaso Lupia, Giuseppe Cariti, Giovanni Di Perri. Efficacy and safety of interferon-free regimens in patients affected by chronic hepatitis C and psychiatric disorders. Journal of Infection and Chemotherapy 2020; 26(1) doi: 10.1016/j.jiac.2019.06.004
58
Lucia Flores-Contreras, Ana S Sandoval-Rodríguez, Mayra G Mena-Enriquez, Silvia Lucano-Landeros, Inmaculada Arellano-Olivera, Arnulfo Álvarez-Álvarez, M Guadalupe Sanchez-Parada, Juan Armendáriz-Borunda. Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C. BMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-131
59
Hiba Sami, Safiya Firoze, Parvez A. Khan. Viral and Fungal Infections of the Central Nervous System: A Microbiological Perspective. 2023;  doi: 10.1007/978-981-99-6445-1_11
60
Harleen K. Dyal, Maria Aguilar, Taft Bhuket, Benny Liu, Edward W. Holt, Sharon Torres, Ramsey Cheung, Robert J. Wong. Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review. Digestive Diseases and Sciences 2015; 60(9) doi: 10.1007/s10620-015-3760-3
61
T. Revuelto Artigas, N. Zaragoza Velasco, X. Gómez Arbones, T. Vidal Ballester, C. Piñol Felis, J.M. Reñe Espinet, A. Betriu Bars. Chronic hepatitis C infection: An independent risk factor for subclinical atheromatosis. Revista Clínica Española (English Edition) 2019; 219(6) doi: 10.1016/j.rceng.2019.02.008
62
Pasquale Ambrosino, Roberta Lupoli, Alessandro Di Minno, Luciano Tarantino, Gaia Spadarella, Paolo Tarantino, Aurelio Nasto, Aldo Celentano, Matteo Nicola Dario Di Minno. The risk of coronary artery disease and cerebrovascular disease in patients with hepatitis C: A systematic review and meta-analysis. International Journal of Cardiology 2016; 221 doi: 10.1016/j.ijcard.2016.06.337
63
Chang Ho Lee, Ji Hyun Kim, Seong-Wook Lee. The role of microRNAs in Hepatitis C Virus replication and related liver diseases. Journal of Microbiology 2014; 52(6) doi: 10.1007/s12275-014-4267-x
64
Akinori Uruha, Satoru Noguchi, Yukiko K. Hayashi, Rie S. Tsuburaya, Takahiro Yonekawa, Ikuya Nonaka, Ichizo Nishino. Hepatitis C virus infection in inclusion body myositis. Neurology 2016; 86(3) doi: 10.1212/WNL.0000000000002291
65
Pasquale Ambrosino, Luciano Tarantino, Livio Criscuolo, Aurelio Nasto, Aldo Celentano, Matteo Nicola Di Minno. The risk of venous thromboembolism in patients with hepatitis C. Thrombosis and Haemostasis 2016; 116(11) doi: 10.1160/TH16-03-0185
66
Tamara Revuelto Artigas, Àngels Betriu Bars, Natividad Zaragoza Velasco, Xavier Gómez Arbones, Teresa Vidal Ballester, Carme Piñol Felis, Josep Maria Reñé Espinet. Antiviral treatment does not improve subclinical atheromatosis in patients with chronic hepatitis caused by hepatitis C virus. Gastroenterología y Hepatología (English Edition) 2019; 42(6) doi: 10.1016/j.gastre.2019.02.031
67
Benli Jia, Dongsheng Yu, Gang Yu, Yunsheng Cheng, Yang Wang, Xiaoqiang Yi, Xiaoping Li, Yong Wang. Naringenin improve hepatitis C virus infection induced insulin resistance by increase PTEN expression via p53-dependent manner. Biomedicine & Pharmacotherapy 2018; 103 doi: 10.1016/j.biopha.2018.04.110
68
Javier Ampuero, Manuel Romero-Gómez. Assessing cardiovascular risk in hepatitis C: An unmet need. World Journal of Hepatology 2015; 7(19): 2214-2219 doi: 10.4254/wjh.v7.i19.2214
69
Maria Mazzitelli, Carlo Torti, Jolanda Sabatino, Greta Luana D’Ascoli, Chiara Costa, Vincenzo Pisani, Elena Raffetti, Salvatore De Rosa, Alessio Strazzulla, Alfredo Focà, Maria Carla Liberto, Ciro Indolfi. Evaluation of cardiac function by global longitudinal strain before and after treatment with sofosbuvir-based regimens in HCV infected patients. BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3426-9
70
Kiyotaka Yamazaki, Dendy Macaulay, Yan Song, Yuri Sanchez Gonzalez. Clinical and Economic Burden of Patients with Chronic Hepatitis C with Versus Without Antiviral Treatment in Japan: An Observational Cohort Study Using Hospital Claims Data. Infectious Diseases and Therapy 2019; 8(2) doi: 10.1007/s40121-019-0234-5
71
Evgeniya V. Shmeleva, Francesco Colucci. Maternal natural killer cells at the intersection between reproduction and mucosal immunity. Mucosal Immunology 2021; 14(5) doi: 10.1038/s41385-020-00374-3
72
Dina Johar, Ahmed Hamed Bedair El-Assal, Mahmoud Mohamed Abou-El-Makarem, Essam Foad A. Hammouda, Mohamed Soliman Hegazy, Samy Zaky. Do oxidized low-density lipoproteins link to extra hepatic manifestations in chronic, non-cirrhotic HCV patients?. Metabolism Open 2025; 25 doi: 10.1016/j.metop.2024.100339
73
Ali Reza Safarpour, Sara Shojaei-Zarghani, Leila Rahmati, Yousef Nikmanesh, Gholam Reza Sivandzadeh, Lida Ahmadi, Saeid Amirizadeh, Mohammad Reza Fattahi. Comparison of Characteristics and Outcomes of Hepatitis B and Hepatitis C Patients in the Fars Hepatitis Registry. Hepatitis Monthly 2024; 24(1) doi: 10.5812/hepatmon-150623
74
Nobukazu Ishizaka, Yuko Ishizaka, Minoru Yamkado. Atherosclerosis as a Possible Extrahepatic Manifestation of Chronic Hepatitis C Virus Infection. Clinical Medicine Insights: Cardiology 2014;  doi: 10.4137/CMC.S17069
75
Clodoveo Ferri, Manuel Ramos-Casals, Anna Linda Zignego, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, David Saadoun, Anne Claire Desbois, Marco Sebastiani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement. Autoimmunity Reviews 2016; 15(12) doi: 10.1016/j.autrev.2016.09.006
76
Vinicius Nunes Cordeiro Leal, Edione Cristina Reis, Alessandra Pontillo. Inflammasome in HIV infection: Lights and shadows. Molecular Immunology 2020; 118 doi: 10.1016/j.molimm.2019.12.001
77
Letitia Toma, Mihai Dodot, Anca Zgura, Nicolae Bacalbasa, Andrei Silaghi, Razvan Simu, Teodora Isac, Adriana Mercan-Stanciu. Calprotectin in viral systemic infections—COVID-19 versus hepatitis C virus. Clinical and Experimental Medicine 2022; 22(2) doi: 10.1007/s10238-021-00743-7
78
Yuan Liu, Li Chen, Ziying Zou, Bing Zhu, Zonghai Hu, Ping Zeng, Lijuan Wu, Jie Xiong. Hepatitis C virus infection induces elevation of CXCL10 in human brain microvascular endothelial cells. Journal of Medical Virology 2016; 88(9) doi: 10.1002/jmv.24504
79
Joshua S Davis, Melissa Young, Sandra Lennox, Tracey Jones, Kim Piera, Robert Pickles, Stephen Oakley. The effect of curing hepatitis C with direct-acting antiviral treatment on endothelial function. Antiviral Therapy 2018; 23(8) doi: 10.3851/IMP3257
80
Marianna Sallustro, Aldo Marrone, Anna Florio. A Case Report on Treatment of Nonhealing Leg Ulcer: Do Not Forget the Underlying Disease. The International Journal of Lower Extremity Wounds 2023; 22(1) doi: 10.1177/1534734621999029
81
Tung Huynh, Johnathan Zhang, Ke-Qin Hu. Hepatitis C Virus Clearance by Direct-acting Antiviral Results in Rapid Resolution of Hepatocytic Injury as Indicated by Both Alanine Aminotransferase and Aspartate Aminotransferase Normalization. Journal of Clinical and Translational Hepatology 2018; 6(3) doi: 10.14218/JCTH.2018.00014
82
Nour Beydoun, Matthew J. Feinstein. Heart Failure in Chronic Infectious and Inflammatory Conditions: Mechanistic Insights from Clinical Heterogeneity. Current Heart Failure Reports 2022; 19(5) doi: 10.1007/s11897-022-00560-3
83
Ahmed Akhter, Adnan Said. Cutaneous Manifestations of Viral Hepatitis. Current Infectious Disease Reports 2015; 17(2) doi: 10.1007/s11908-014-0452-7
84
O. V. Masalova, E. I. Lesnova, K. Yu. Permyakova, E. I. Samokhvalov, A. V. Ivanov, S. N. Kochetkov, A. A. Kushch. Effect of Hepatitis C virus proteins on the production of proinflammatory and profibrotic cytokines in Huh7.5 human hepatoma cells. Molecular Biology 2016; 50(3) doi: 10.1134/S0026893316020163
85
Mohamed A. Abd El Hafez, Zeinab Abdel Aziz Kasemy. Effect of direct-acting antivirals on platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with hepatitis C virus-related thrombocytopenia. The Egyptian Journal of Internal Medicine 2019; 31(3) doi: 10.4103/ejim.ejim_14_19
86
Rei-Yeuh Chang, Sheri Hsueh-Hua Ho, Han-Lin Tsai, Malcolm Koo. Association of anxiety and depression with chronic liver diseases in patients with noncardiac chest pain: A cross-sectional study. Medicine 2022; 101(31) doi: 10.1097/MD.0000000000029620
87
Melissa A. Sheiko, Hugo R. Rosen. Hepatitis C Virus II. 2016;  doi: 10.1007/978-4-431-56101-9_3
88
Javier A. Pagan, Marco Ladino, David Roth. End-Stage Renal Disease and Treatment of Hepatitis C Virus Infection. Current Hepatology Reports 2018; 17(1) doi: 10.1007/s11901-018-0387-9
89
Hiba Mechahougui, Léna Royston, Catia Vieira Gomes, Laurent Kaiser, Thibaud Koessler, Timothée Olivier, Nicolas Mach, S. Intidhar Labidi-Galy, Kaushal Parikh, Alfredo Addeo. Efficacy of Immune Checkpoint Inhibitors and Oncoviruses in Solid Tumors. Clinical Cancer Research 2026; 32(6) doi: 10.1158/1078-0432.CCR-25-2846
90
Tram T. Tran, Darshan Mehta, Federico Mensa, Caroline Park, Yanjun Bao, Yuri Sanchez Gonzalez. Pan-Genotypic Hepatitis C Treatment with Glecaprevir and Pibrentasvir for 8 Weeks Resulted in Improved Cardiovascular and Metabolic Outcomes and Stable Renal Function: A Post-Hoc Analysis of Phase 3 Clinical Trials. Infectious Diseases and Therapy 2018; 7(4) doi: 10.1007/s40121-018-0218-x
91
Tamara Revuelto Artigas, Àngels Betriu Bars, Natividad Zaragoza Velasco, Xavier Gómez Arbones, Teresa Vidal Ballester, Carme Piñol Felis, Josep Maria Reñé Espinet. El tratamiento antiviral no mejora la ateromatosis subclínica en pacientes con hepatitis crónica por virus de la hepatitis C. Gastroenterología y Hepatología 2019; 42(6) doi: 10.1016/j.gastrohep.2019.02.002
92
Beatriz Álvarez, Clara Restrepo, Marcial García, María A. Navarrete-Muñoz, María A. Jiménez-Sousa, Laura Prieto, Alfonso Cabello, Sara Nistal, Salvador Resino, Miguel Górgolas, Norma Rallón, José M. Benito. Liver Stiffness Hinders Normalization of Systemic Inflammation and Endothelial Activation after Hepatitis C Virus (HCV) Eradication in HIV/HCV Coinfected Patients. Vaccines 2020; 8(2) doi: 10.3390/vaccines8020323
93
Takanobu Iwadare, Takefumi Kimura, Naoki Tanaka, Tomoo Yamazaki, Shun-ichi Wakabayashi, Taiki Okumura, Hiroyuki Kobayashi, Yuki Yamashita, Sai P. Pydi, Tomoyuki Nakajima, Mai Iwaya, Ayumi Sugiura, Satoru Joshita, Takeshi Uehara, Takeji Umemura. Circulating thrombospondin 2 levels reflect fibrosis severity and disease activity in HCV-infected patients. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-23357-9
94
Silvana Zito, Simona Mercurio, Giuseppe Mercurio, Alessandro Pigoni, Gian Mario Mandolini, Elisabetta Caletti. Neurocognitive impairment and cerebral metabolic alterations induced by direct hepatitis C virus neuroinvasion: implications on quality of life. Minerva Psichiatrica 2019; 60(2) doi: 10.23736/S0391-1772.19.02012-0
95
Tangui Barré, Teresa Rojas Rojas, Karine Lacombe, Camelia Protopopescu, Isabelle Poizot-Martin, Marie Libérée Nishimwe, David Zucman, Laure Esterle, Eric Billaud, Hugues Aumaitre, Olivier Bouchaud, David Rey, Lionel Piroth, Dominique Salmon-Ceron, Linda Wittkop, Philippe Sogni, Maria Patrizia Carrieri, Lawrence Serfaty, Fabienne Marcellin. Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH). Expert Review of Anti-infective Therapy 2021; 19(9) doi: 10.1080/14787210.2021.1884545
96
Alaa Badawi, Giancarlo Di Giuseppe, Paul Arora, Hans Tillmann. Cardiovascular disease risk in patients with hepatitis C infection: Results from two general population health surveys in Canada and the United States (2007-2017). PLOS ONE 2018; 13(12) doi: 10.1371/journal.pone.0208839
97
Sara C. LaHue, Dolores Torres, Nicole Rosendale, Vineeta Singh. Stroke Characteristics, Risk Factors, and Outcomes in Transgender Adults. The Neurologist 2019; 24(2) doi: 10.1097/NRL.0000000000000226
98
G. N. Khokhlova, O. V. Koltsova, E. R. Isaeva, E. V. Boeva, V. V. Rassokhin. Cognitive training as a technology for protecting and restoring the functions of the central nervous system in patients with infectious pathology. HIV Infection and Immunosuppressive Disorders 2023; 15(2) doi: 10.22328/2077-9828-2023-15-2-19-36
99
Sandra J. Page, Maria M. Rivera, David E. Kleiner, Xiongce Zhao, Sungyoung Auh, Elaine F. Remmers, Theo Heller. Three variants in the nicotinamide adenine dinucleotide phosphate oxidase complex are associated with HCV‐related liver damage. Hepatology Communications 2017; 1(9) doi: 10.1002/hep4.1103
100
D. L. Sulima, S. S. Suleymanova, A. A. Yakovlev, V. N. Koryagin, V. V. Rassokhin. Virological failures of primary interferon-free therapy in patients with chronic HCV RNA viremia and successful repeated interferon-free therapy. HIV Infection and Immunosuppressive Disorders 2022; 14(3) doi: 10.22328/2077-9828-2022-14-3-100-109
101
Wey-Yil Lin, Ming-Shyan Lin, Yi-Hsin Weng, Tu-Hsueh Yeh, Yu-Sheng Lin, Po-Yu Fong, Yih-Ru Wu, Chin-Song Lu, Rou-Shayn Chen, Ying-Zu Huang. Association of Antiviral Therapy With Risk of Parkinson Disease in Patients With Chronic Hepatitis C Virus Infection. JAMA Neurology 2019; 76(9) doi: 10.1001/jamaneurol.2019.1368
102
Ciro Romano, Olga Tortorella, Liliana Dalla Mora, Dario Di Stasio, Ausilia Sellitto, Luigi Elio Adinolfi, Aldo Marrone. Prevalence and Outcome of Serum Autoantibodies in Chronic Hepatitis C Patients Undergoing Direct-Acting Antiviral Treatment. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.882064
103
Chun‐Zhong Lin, Rong‐Wen Ou, Yu‐Hai Hu. Lentiviral‐mediated microRNA‐26b up‐regulation inhibits proliferation and migration of hepatocellular carcinoma cells. The Kaohsiung Journal of Medical Sciences 2018; 34(10) doi: 10.1016/j.kjms.2018.05.003
104
Petr Husa, Svatava Snopkova, Jirina Zavrelova, Filip Zlamal, Radek Svacinka, Petr Husa. Circulating microparticles in patients with chronic hepatitis C and changes during direct-acting antiviral therapy. Biomedical Papers 2021; 165(2) doi: 10.5507/bp.2021.023
105
Vicente Soriano, Juan Berenguer. Extrahepatic comorbidities associated with hepatitis C virus in HIV-infected patients. Current Opinion in HIV and AIDS 2015; 10(5) doi: 10.1097/COH.0000000000000175
106
KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney International Supplements 2018; 8(3) doi: 10.1016/j.kisu.2018.06.001
107
Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama-Kohara. Effects of oxidative stress on viral infections: an overview. npj Viruses 2025; 3(1) doi: 10.1038/s44298-025-00110-3
108
Saba Munawar, Ameer Fawad Zahoor. Carbazole Tethered Triazoles as Potential NS5A/NS5B Inhibitors: Synthesis, Molecular Docking, MD Simulation, ADMET and DFT Studies. ChemistrySelect 2026; 11(10) doi: 10.1002/slct.202506286
109
Hu Li, Meng-Hao Huang, Jian-Dong Jiang, Zong-Gen Peng. Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy. World Journal of Gastroenterology 2018; 24(47): 5297-5311 doi: 10.3748/wjg.v24.i47.5297
110
Rahul Chaudhari, Sherouk Fouda, Ashik Sainu, Joseph M Pappachan. Metabolic complications of hepatitis C virus infection. World Journal of Gastroenterology 2021; 27(13): 1267-1282 doi: 10.3748/wjg.v27.i13.1267
111
Alsu Z. Malikova, Anastasia S. Shcherbakova, Konstantin A. Konduktorov, Anastasia S. Zemskaya, Alexandra A. Dalina, Vladimir I. Popenko, Olga G. Leonova, Alexei V. Morozov, Nikolay N. Kurochkin, Olga A. Smirnova, Sergey N. Kochetkov, Maxim V. Kozlov. Pre-Senescence Induction in Hepatoma Cells Favors Hepatitis C Virus Replication and Can Be Used in Exploring Antiviral Potential of Histone Deacetylase Inhibitors. International Journal of Molecular Sciences 2021; 22(9) doi: 10.3390/ijms22094559
112
Lenche Kostadinova, Carey L Shive, Donald D Anthony. Elevated Autotaxin and LPA Levels during Chronic Viral Hepatitis and Hepatocellular Carcinoma Associate with Systemic Immune Activation. Cancers 2019; 11(12) doi: 10.3390/cancers11121867
113
Matheus De Lucca Thomaz, Carolina Pinto Vieira, Juciene Aparecida Caris, Maria Paula Marques, Adriana Rocha, Tiago Antunes Paz, Rosamar Eulira Fontes Rezende, Vera Lucia Lanchote. Liver Fibrosis Stages Affect Organic Cation Transporter 1/2 Activities in Hepatitis C Virus-Infected Patients. Pharmaceuticals 2024; 17(7) doi: 10.3390/ph17070865
114
Hanan Mahmoud Fayed, Hasan Sedeek Mahmoud, Abdallah Elaiw Mohamed Ali. <p>The Utility of Retinol-Binding Protein 4 in Predicting Liver Fibrosis in Chronic Hepatitis C Patients in Response to Direct-Acting Antivirals</p>. Clinical and Experimental Gastroenterology 2020;  doi: 10.2147/CEG.S229689
115
Tomasz Mikuła, Magdalena Suchacz, Mariusz Sapuła, Alicja Wiercińska-Drapało. Significance of Vascular Cell Adhesion Molecule-1 and Tumor Necrosis Factor-Alpha in HIV-Infected Patients. Journal of Clinical Medicine 2022; 11(3) doi: 10.3390/jcm11030514
116
Thanathip Suenghataiphorn, Narisara Tribhuddharat, Pojsakorn Danpanichkul, Thitiphan Srikulmontri, Narathorn Kulthamrongsri. Hepatitis C increases acute myocardial infarction risk in people living with HIV: A systematic review and meta-analysis. International Journal of STD & AIDS 2025; 36(10) doi: 10.1177/09564624251348688
117
T. Vescovo, G. Refolo, G. Vitagliano, G.M. Fimia, M. Piacentini. Molecular mechanisms of hepatitis C virus–induced hepatocellular carcinoma. Clinical Microbiology and Infection 2016; 22(10) doi: 10.1016/j.cmi.2016.07.019
118
Stephanie T. Chan, Jiyoung Lee, Mansi Narula, J.-H. James Ou, M. S. Diamond. Suppression of Host Innate Immune Response by Hepatitis C Virus via Induction of Autophagic Degradation of TRAF6. Journal of Virology 2016; 90(23) doi: 10.1128/JVI.01365-16
119
Albert Do, Denise A. Esserman, Supriya Krishnan, Joseph K. Lim, Tamar H. Taddei, Ronald G. Hauser, Janet P. Tate, Vincent Lo Re, Amy C. Justice. Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals. Journal of General Internal Medicine 2020; 35(7) doi: 10.1007/s11606-020-05782-6
120
Georg Peschel, Jonathan Grimm, Christa Buechler, Manuela Gunckel, Kirstin Pollinger, Elisabeth Aschenbrenner, Sylvia Kammerer, Ernst-Michael Jung, Michael Haimerl, Jens Werner, Martina Müller, Kilian Weigand. Liver stiffness assessed by shear-wave elastography declines in parallel with immunoregulatory proteins in patients with chronic HCV infection during DAA therapy. Clinical Hemorheology and Microcirculation 2021; 79(4) doi: 10.3233/CH-211193
121
Fabrizio Fabrizi, Francesca M. Donato, Piergiorgio Messa. Hepatitis C and Its Metabolic Complications in Kidney Disease. Annals of Hepatology 2017; 16(6) doi: 10.5604/01.3001.0010.5275
122
Mohadeseh Zarei Ghobadi, Mohammad Amin Nooraniyan Esfehani, Shohreh Shahmahmoodi, Ahmad Nejati, Abolfazl Keshavarz, Katayoun Samimi‐Rad. Bioinformatics Analysis of Persistent Dysregulated Expression of Genes Involved in HCV‐Induced Neurological Disorders and Liver Injuries After DAA Treatment Through Weighted Gene Co‐Expression Network Analysis. Health Science Reports 2025; 8(11) doi: 10.1002/hsr2.71488
123
Lisa I. Backus, Pamela S. Belperio, Troy A. Shahoumian, Larry A. Mole. Direct‐acting antiviral sustained virologic response: Impact on mortality in patients without advanced liver disease. Hepatology 2018; 68(3) doi: 10.1002/hep.29811
124
Ahmed Hussein, Mohamed Abdel Ghany, Hossam Eldin M. Mahmoud. Short- and long-term outcomes following percutaneous coronary intervention in hepatitis C virus seropositive patients. The Egyptian Heart Journal 2020; 72(1) doi: 10.1186/s43044-020-00079-9
125
Elena Grossini, Carlo Smirne, Sakthipriyan Venkatesan, Stelvio Tonello, Davide D’Onghia, Rosalba Minisini, Vincenzo Cantaluppi, Pier Paolo Sainaghi, Cristoforo Comi, Adele Tanzi, Benedetta Bussolati, Mario Pirisi. Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells. International Journal of Molecular Sciences 2023; 24(12) doi: 10.3390/ijms241210197
126
Peng Zhou, Gang Huang, Yuanyin Zhao, Dan Zhong, Zhizhen Xu, Yijun Zeng, Yan Zhang, Song Li, Fengtian He. MicroRNA-363-mediated downregulation of S1PR1 suppresses the proliferation of hepatocellular carcinoma cells. Cellular Signalling 2014; 26(6) doi: 10.1016/j.cellsig.2014.02.020
127
Shilu Mathew, Muhammed Faheem, Sara M Ibrahim, Waqas Iqbal, Bisma Rauff, Kaneez Fatima, Ishtiaq Qadri. Hepatitis C virus and neurological damage. World Journal of Hepatology 2016; 8(12): 545-556 doi: 10.4254/wjh.v8.i12.545
128
Shuangjin Yu, Chang Su, Xunrong Luo. Impact of infection on transplantation tolerance. Immunological Reviews 2019; 292(1) doi: 10.1111/imr.12803
129
Abhinav Vepa, Joseph P. Bae, Faheem Ahmed, Manish Pareek, Kamlesh Khunti. COVID-19 and ethnicity: A novel pathophysiological role for inflammation. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2020; 14(5) doi: 10.1016/j.dsx.2020.06.056
130
Joana R. N. Lemos, Khemraj Hirani, Matthias von Herrath. Immunological and virological triggers of type 1 diabetes: insights and implications. Frontiers in Immunology 2024; 14 doi: 10.3389/fimmu.2023.1326711
131
Chun-Hsien Chen, Yung-Yu Hsieh, Wei-Ming Chen, Chien-Heng Shen, Kuo-Liang Wei, Kao-Chi Chang, Yuan-Jie Ding, Sheng-Nan Lu, Chao-Hung Hung, Te-Sheng Chang. Weight Gain and Increased Body Mass Index in Patients with Hepatitis C after Eradication Using Direct-Acting Antiviral Therapy in Taiwan. Diagnostics 2024; 14(2) doi: 10.3390/diagnostics14020213
132
G. Oriolo, E. Egmond, Z. Mariño, M. Cavero, R. Navines, L. Zamarrenho, R. Solà, J. Pujol, N. Bargallo, X. Forns, R. Martin‐Santos. Systematic review with meta‐analysis: neuroimaging in hepatitis C chronic infection. Alimentary Pharmacology & Therapeutics 2018; 47(9) doi: 10.1111/apt.14594
133
Jung-Sheng Yu, Wei-Chun Chen, Chin-Kai Tseng, Chun-Kuang Lin, Yao-Chin Hsu, Yen-Hsu Chen, Jin-Ching Lee, Stephen J Polyak. Sulforaphane Suppresses Hepatitis C Virus Replication by Up-Regulating Heme Oxygenase-1 Expression through PI3K/Nrf2 Pathway. PLOS ONE 2016; 11(3) doi: 10.1371/journal.pone.0152236
134
Alexis Ogdie, Wyki Gina Pang, Kimberly A Forde, Bhangle D Samir, Lakeisha Mulugeta, Kyong-Mi Chang, David E Kaplan, Valerianna K Amorosa, Jay R Kostman, Rajender K Reddy, Ralph H Schumacher, Vincent Lo Re. Prevalence and risk factors for patient-reported joint pain among patients with HIV/Hepatitis C coinfection, Hepatitis C monoinfection, and HIV monoinfection. BMC Musculoskeletal Disorders 2015; 16(1) doi: 10.1186/s12891-015-0552-z
135
Salvatore Petta. Hepatitis C virus and cardiovascular: A review. Journal of Advanced Research 2017; 8(2) doi: 10.1016/j.jare.2016.06.001
136
Rossella Cianci, Mario Caldarelli, Paola Brani, Annalisa Bosi, Alessandra Ponti, Cristina Giaroni, Andreina Baj. Role of the Virome in Vaccine-Induced Immunization. Vaccines 2025; 13(9) doi: 10.3390/vaccines13090895
137
Hyo Geun Choi, Jae Seung Soh, Jae Sung Lim, Song Yong Sim, Suk Woo Lee. Association between dementia and hepatitis B and C virus infection. Medicine 2021; 100(29) doi: 10.1097/MD.0000000000026476
138
Atefe Ghamar Talepoor, Mehrnoosh Doroudchi. Immunosenescence in atherosclerosis: A role for chronic viral infections. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.945016
139
Q.‐t. Huang, Q. Huang, M. Zhong, S.‐s. Wei, W. Luo, F. Li, Y.‐h. Yu. Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta‐analysis of observational studies. Journal of Viral Hepatitis 2015; 22(12) doi: 10.1111/jvh.12430
140
Bin Tang, Gangcai Zhu, Changhan Chen, Siyuan Zheng, Yuting Pu, Yimin Xu, Huimei Huang, Gang Wang, Donghai Huang, Yong Liu, Xin Zhang. Hepatitis C Virus RNA Transcript Associates with Prognosis in Non‐human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma. The Laryngoscope 2021; 131(8) doi: 10.1002/lary.29422
141
Waleed Qassem Farie, Saleh Salem Bahaj, Anwar Kassem Al-Madhagi, Sarosh Sher Ali, Aref Noman, Waleed Yahya Alkassar. Environmental triggers of autoimmune hepatitis: a clinical perspective from Yemeni patients. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1757477
142
Frank Xing, Luca Marsili, Daniel D. Truong. Parkinsonism in viral, paraneoplastic, and autoimmune diseases. Journal of the Neurological Sciences 2022; 433 doi: 10.1016/j.jns.2021.120014
143
L I Tkachenko, V V Maleev. The role of systemic inflammation in the pathogenesis of insulin resistance and metabolic syndrome in patients with chronic hepatitis C. Terapevticheskii arkhiv 2018; 90(11) doi: 10.26442/terarkh201890114-31
144
Hila Shalom-Elazari, Hadas Zazrin-Greenspon, Hadassa Shaked, Jordan H. Chill. Global fold and backbone dynamics of the hepatitis C virus E2 glycoprotein transmembrane domain determined by NMR. Biochimica et Biophysica Acta (BBA) - Biomembranes 2014; 1838(11) doi: 10.1016/j.bbamem.2014.07.023
145
Napon Hiranburana, Jiratchaya Sophonphan, Stephen J Kerr, Sasiwimol Ubolyam, Warat Usawakidwiree, Pattama Torvorapanit, Gompol Suwanpimolkul, Weeraya Phaisal, Pajaree Chariyavilaskul, Yong-Soon Cho, Jae-Gook Shin, Surakameth Mahasirimongkol, Anchalee Avihingsanon. NAT2 Polymorphisms and Antituberculosis-Induced Hepatotoxicity in Thai People Living With HIV: Insights From a Pharmacogenetic–Pharmacokinetic Cohort Study. The Journal of Infectious Diseases 2026; 233(2) doi: 10.1093/infdis/jiaf511
146
Caitlin A. Moran, Lauren F. Collins, Nour Beydoun, Puja K. Mehta, Yetunde Fatade, Ijeoma Isiadinso, Tené T. Lewis, Brittany Weber, Jill Goldstein, Igho Ofotokun, Arshed Quyyumi, May Y. Choi, Kehmia Titanji, Cecile D. Lahiri. Cardiovascular Implications of Immune Disorders in Women. Circulation Research 2022; 130(4) doi: 10.1161/CIRCRESAHA.121.319877
147
Nick Nielsen, Sofie Jespersen, Julie Gaardbo, Caroline Arnbjerg, Mette Clausen, Mette Kjær, Jan Gerstoft, Vibe Ballegaard, Sisse Ostrowski, Susanne Nielsen. Impaired Platelet Aggregation and Rebalanced Hemostasis in Patients with Chronic Hepatitis C Virus Infection. International Journal of Molecular Sciences 2017; 18(5) doi: 10.3390/ijms18051016
148
Marc Ganz, Christopher Alessandro, Menachem Jacobs, Yehuda Gejerman, Daniel Miller, Frederick Okoye, Scott Jamieson, Andrew Winer. Exploring the Relationship Between Hepatitis C Virus Infection and Prostate Cancer Risk: A National Health and Nutrition Examination Survey Analysis. Cureus 2024;  doi: 10.7759/cureus.54523
149
N. Y. Mapoure, M. N. Budzi, S. A. F. B. Eloumou, A. Malongue, C. Okalla, H. N. Luma, Yury E Khudyakov. Neurological manifestations in chronic hepatitis C patients receiving care in a reference hospital in sub-Saharan Africa: A cross-sectional study. PLOS ONE 2018; 13(3) doi: 10.1371/journal.pone.0192406
150
Rosa Zampino, Anna Florio, Nicola Coppola, Grazia Cirillo, Margherita Macera, Aldo Marrone, Luigi Elio Adinolfi, Emanuele Miraglia del Giudice. PNPLA3 I148M variant as a risk factor for carotid atherosclerosis in chronic hepatitis C. International Journal of Cardiology 2014; 172(1) doi: 10.1016/j.ijcard.2013.12.231
151
Qingsong Xu, Meisi Liu, Qishun Liu, Wenxia Wang, Yuguang Du, Heng Yin. The inhibition of LPS-induced inflammation in RAW264.7 macrophages via the PI3K/Akt pathway by highly N-acetylated chitooligosaccharide. Carbohydrate Polymers 2017; 174 doi: 10.1016/j.carbpol.2017.07.051
152
Faheem Ahmed, In Suk Kang, Kyung Hwan Kim, Arun Asif, Chethikkattuveli Salih Abdul Rahim, Anupama Samantasinghar, Fida Hussain Memon, Kyung Hyun Choi. Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches. Journal of Medical Virology 2023; 95(4) doi: 10.1002/jmv.28693
153
Shazia Tabassum Hakim, Cayatineto HW. Prospective approaches to target bovine viral diarrhea virus and hepatitis C virus using miRNA-based inhibitors. Journal of Human Virology & Retrovirology 2024; 11(1) doi: 10.15406/jhvrv.2024.11.00278
154
Wesal Elgretli, Tianyan Chen, Nadine Kronfli, Giada Sebastiani. Hepatitis C Virus-Lipid Interplay: Pathogenesis and Clinical Impact. Biomedicines 2023; 11(2) doi: 10.3390/biomedicines11020271
155
Sherief Abd-Elsalam, Yousry Esam-Eldin Abo-Amer, Mohamed El-Abgeegy, Samah A. Elshweikh, Heba Fadl Elsergany, Rehab Ahmed, Mahmoud Elkadeem, Nehad Hawash, Shaimaa Soliman, Rehab Badawi, Ayman Mohammed Abdou Elguindy, Moataz Yousry Soliman, Ahmed Abdelhaleem Mohmed, Loai Mansour. Efficacy and safety of ombitasvir/paritaprevir/ritonavir/ribavirin in management of Egyptian chronic hepatitis C virus patients with chronic kidney disease. Medicine 2020; 99(42) doi: 10.1097/MD.0000000000021972
156
Roger Bedimo, Naim M. Maalouf, Vincent Lo Re. Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture. Current Opinion in HIV and AIDS 2016; 11(3) doi: 10.1097/COH.0000000000000259
157
Yuwei Zhang, Mohamed El-Far, Franck P. Dupuy, Mohamed S. Abdel-Hakeem, Zhong He, Francesco Andrea Procopio, Yu Shi, Elias K. Haddad, Petronela Ancuta, Rafick-Pierre Sekaly, Elias A. Said. HCV RNA Activates APCs via TLR7/TLR8 While Virus Selectively Stimulates Macrophages Without Inducing Antiviral Responses. Scientific Reports 2016; 6(1) doi: 10.1038/srep29447
158
Giovanni Targher, Christopher D. Byrne. Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease. Nature Reviews Nephrology 2017; 13(5) doi: 10.1038/nrneph.2017.16
159
Alessia Gallo, Monica Miele, Ester Badami, Pier Giulio Conaldi. Molecular and cellular interplay in virus-induced tumors in solid organ recipients. Cellular Immunology 2019; 343 doi: 10.1016/j.cellimm.2018.02.010
160
Vasiliki Katsi, Ioannis Felekos, Stamatios Skevofilax, Constantina Aggeli, Dimitris Tousoulis, Christodoulos Stefanadis, Ioannis Kallikazaros. Cardiovascular Disease and Hepatitis C Virus Infection. Cardiology in Review 2015; 23(1) doi: 10.1097/CRD.0000000000000031
161
T. Revuelto Artigas, N. Zaragoza Velasco, X. Gómez Arbones, T. Vidal Ballester, C. Piñol Felis, J.M. Reñe Espinet, A. Betriu Bars. Infección crónica por el virus de la hepatitis C: un factor de riesgo independiente para la ateromatosis subclínica. Revista Clínica Española 2019; 219(6) doi: 10.1016/j.rce.2018.12.007
162
Jyoti Barokar, Allen McCutchan, Reena Deutsch, Bin Tang, Mariana Cherner, Ajay R. Bharti. Neurocognitive impairment is worse in HIV/HCV-coinfected individuals with liver dysfunction. Journal of NeuroVirology 2019; 25(6) doi: 10.1007/s13365-019-00767-6
163
Qiankun Wang, Yi Wang, Tongxin Yin, Yuting Feng, Huihao Ren, Xiao Xiao, Jiaoyuan Li, Liming Cheng. Genetic and transcriptional insights reveal hepatitis C virus as a driver of kidney cancer. Infectious Agents and Cancer 2025; 20(1) doi: 10.1186/s13027-025-00693-9
164
Dario Di Stasio, Alberta Lucchese, Antonio Romano, Luigi Elio Adinolfi, Rosario Serpico, Aldo Marrone. The clinical impact of direct-acting antiviral treatment on patients affected by hepatitis C virus-related oral lichen planus: a cohort study. Clinical Oral Investigations 2022; 26(8) doi: 10.1007/s00784-022-04507-9
165
Vincent Soriano, Pablo Labarga, José V Fernandez-Montero, Carmen de Mendoza, Isabella Esposito, Laura Benítez-Gutiérrez, Pablo Barreiro. Hepatitis C Cure with Antiviral Therapy – Benefits beyond the Liver. Antiviral Therapy 2016; 21(1) doi: 10.3851/IMP2975
166
Chih-Wen Wang, Chung-Feng Huang, Ming-Lun Yeh, Szu-Chia Chen, Chih-Hsing Hung, Chao-Hung Kuo, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming Lung-Yu. Hepatitis C virus infection associated with coronary and thoracic aortic atherosclerosis. The American Journal of the Medical Sciences 2024; 368(3) doi: 10.1016/j.amjms.2024.02.004
167
Yosuke Hashimoto, Minoru Tada, Manami Iida, Shotaro Nagase, Tomoyuki Hata, Akihiro Watari, Yoshiaki Okada, Takefumi Doi, Masayoshi Fukasawa, Kiyohito Yagi, Masuo Kondoh. Generation and characterization of a human–mouse chimeric antibody against the extracellular domain of claudin-1 for cancer therapy using a mouse model. Biochemical and Biophysical Research Communications 2016; 477(1) doi: 10.1016/j.bbrc.2016.06.025
168
Waleed M. Elguindy, Waleed M. Serag. Cardiac echoparameters (geometry and dimensions), interleukin 6, and anthropometric measurements in Egyptian adolescents with hepatitis C and hepatocellular carcinoma. Egyptian Liver Journal 2017; 7(3 and 4) doi: 10.1097/01.ELX.0000526967.41371.51
169
Danijel Galun, Dragan Basaric, Marinko Zuvela, Predrag Bulajic, Aleksandar Bogdanovic, Nemanja Bidzic, Miroslav Milicevic. Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols. World Journal of Hepatology 2015; 7(20): 2274-2291 doi: 10.4254/wjh.v7.i20.2274
170
Bisma Rauff, Mark W Douglas. Role of Fibrogenic and Inflammatory Cytokines in HCV-Induced Fibrosis. Future Virology 2015; 10(12) doi: 10.2217/fvl.15.102
171
Arnolfo Petruzziello. Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma. The Open Virology Journal 2018; 12(1) doi: 10.2174/1874357901812010026
172
Riccardo NEVOLA, Carlo ACIERNO, Pia C. PAFUNDI, Luigi E. ADINOLFI. Chronic hepatitis C infection induces cardiovascular disease and type 2 diabetes: mechanisms and management. Minerva Medica 2021; 112(2) doi: 10.23736/S0026-4806.20.07129-3
173
Shahram Jalilian, Mona Vasei, Ashkan Garshasbi, Seyed Salaheddin Nabavi, Mohammad‐Navid Bastani. Viral intruders in the heart: A review of RNA viruses and their role in cardiac disorders. APMIS 2025; 133(1) doi: 10.1111/apm.13500
174
Wei-Chun Chen, Chin-Kai Tseng, Yen-Hsu Chen, Chun-Kuang Lin, Shih-hsien Hsu, Shen-Nien Wang, Jin-Ching Lee, Stephen J Polyak. HCV NS5A Up-Regulates COX-2 Expression via IL-8-Mediated Activation of the ERK/JNK MAPK Pathway. PLOS ONE 2015; 10(7) doi: 10.1371/journal.pone.0133264
175
Roger Bedimo, James Cutrell, Song Zhang, Henning Drechsler, Ang Gao, Geri Brown, Irfan Farukhi, Rosinda Castanon, Pablo Tebas, Naim M. Maalouf. Mechanisms of bone disease in HIV and hepatitis C virus. AIDS 2016; 30(4) doi: 10.1097/QAD.0000000000000952
176
Khadija Rebbani, Kyoko Tsukiyama-Kohara, Maria G. Isaguliants. HCV‐Induced Oxidative Stress: Battlefield‐Winning Strategy. Oxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/7425628
177
Mina Nakagawa, Yasuhiro Asahina, Sei Kakinuma, Ryuichi Okamoto. Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR. Journal of Gastroenterology 2023; 58(4) doi: 10.1007/s00535-022-01940-1
178
Nahum Méndez-Sánchez, Carlos E. Coronel-Castillo, Mariana Michelle Ramírez-Mejía. Chronic Hepatitis C Virus Infection, Extrahepatic Disease and the Impact of New Direct-Acting Antivirals. Pathogens 2024; 13(4) doi: 10.3390/pathogens13040339
179
Elham A. Hassan, Abeer S. Abd El-Rehim, Gehan S. Seifeldein, Ghaydaa A. Shehata. Minimal hepatic encephalopathy in patients with liver cirrhosis: Magnetic resonance spectroscopic brain findings versus neuropsychological changes. Arab Journal of Gastroenterology 2014; 15(3-4) doi: 10.1016/j.ajg.2014.09.003
180
Moema S. Santana, Rute Lopes, Isabela H. Peron, Carla R. Cruz, Ana M.M. Gaspar, Paulo I. Costa. Natural Bioactive Compounds as Adjuvant Therapy for Hepatitis C Infection. Current Nutrition & Food Science 2021; 17(5) doi: 10.2174/1573401316999201009152726
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.